20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

The Importance of Intermediates in Targeted Cancer Therapies: The Case of Nilotinib

Targeted cancer therapies have revolutionized the treatment landscape for many difficult-to-treat diseases, offering more precise and often less toxic alternatives to traditional chemotherapy. Nilotinib, a potent tyrosine kinase inhibitor, stands as a prime example of such an advancement, particularly in managing Chronic Myelogenous Leukemia (CML). However, the efficacy of these sophisticated drugs is intrinsically linked to the quality of the pharmaceutical intermediates used in their synthesis. Ethyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate (CAS 641569-97-3) is a prime example of such a critical intermediate.

The journey from basic chemical compounds to a life-saving drug like Nilotinib involves a complex series of chemical transformations. Each step requires meticulously produced intermediates, and any compromise in quality can have profound implications for the final product's safety and therapeutic effect. Ethyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate serves as a foundational component, providing a key structural element that facilitates the drug's interaction with its target proteins.

Manufacturers specializing in pharmaceutical intermediates understand the immense responsibility associated with supplying these materials. A commitment to high purity, typically exceeding 98.0%, and consistent batch-to-batch quality is paramount. For companies in the pharmaceutical sector, selecting reputable suppliers, often found in established chemical manufacturing regions such as China, is a critical decision. These suppliers must not only meet stringent quality standards but also possess the expertise in complex organic synthesis required for compounds like CAS 641569-97-3.

The development and availability of effective targeted cancer therapies depend heavily on the robust supply chain of these essential intermediates. By ensuring the quality and accessibility of compounds like Ethyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate, the pharmaceutical industry can continue to innovate and provide patients with more effective treatment options, significantly improving prognoses for diseases like CML.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Sourcing High-Purity Pyrimidine Intermediates: A Guide for Pharmaceutical Manufacturers

Next: Chemical Building Blocks for Pharmaceutical Innovation: Focus on CAS 641569-97-3

All Rights Reserved